BTTX’s Market Ups and Downs: What’s Behind the 2023 Stock Performance?

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The metric has seen a significant loss of -84.62% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -78.39%. Over the past 30 days, the price of BTTX has leaped by -22.42%. And in the last five days, it has surged by 10.97%.

The current stock price for Better Therapeutics Inc (BTTX) is $0.17. The stock experienced a significant increase during the last trading session, reaching $0.1711 after opening at $0.166. It dipped to a low of $0.1601 before ultimately closing at $0.16.

Elon Musk just Triggered a BOOM in These Stocks

Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"

Click Here to Download the FREE Report.


Better Therapeutics Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $1.61 on 04/10/23, and the lowest price during the same period was recorded at $0.14 on 10/31/23.

52-week price history of BTTX Stock

A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Better Therapeutics Inc’s current trading price is -89.45% away from its 52-week high, while its distance from the 52-week low is 24.29%. The stock’s price range over this timeframe has been between $0.14 and $1.61. The shares of the Healthcare sector company recorded a trading volume of approximately 1.09 million for the day, which was comparatively lower than the average daily volume of 1.58 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Better Therapeutics Inc (BTTX) has experienced a quarterly decline of -74.25% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 8.05M and boasts a workforce of 54 employees.

Expert Opinions: Analysts’ Ratings for Better Therapeutics Inc

As of right now, 3 analysts are rating Better Therapeutics Inc as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.5313, with a change in price of -0.7591. Similarly, Better Therapeutics Inc recorded 1,580,115 in trading volume during the last 100 days, posting a change of -81.71%.

BTTX Stock Stochastic Average

The raw stochastic average for Better Therapeutics Inc over the last 50 days is presently at 6.69%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 42.51%. Further, the company’s Stochastic %K and %D values for the last 20 days were 30.24% and 22.55%, respectively.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts